We are live on
!
Find out more
AIM
Acrospire Investment Management Portfolio holdings
AUM
$33K
1-Year Est. Return
24.6%
This Fund
S&P 500
This Quarter
Est. Return
+10.71%
1 Year Est. Return
+24.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$92.6M
(+62%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
32.4%
Top 10 Holdings %
Top 10 Hldgs %
2.66%
Holding
2,710
New
740
Increased
896
Reduced
491
Closed
523
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$932K |
| 2 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
+$644K |
| 3 |
NNA
Navios Maritime Acquisition Corporation
NNA
|
+$637K |
| 4 |
Archer Daniels Midland
ADM
|
+$588K |
| 5 |
Nu Skin
NUS
|
+$560K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ennis
EBF
|
+$492K |
| 2 |
GK
G&K Services Inc
GK
|
+$284K |
| 3 |
HMSY
HMS Holdings Corp.
HMSY
|
+$279K |
| 4 |
Vera Bradley
VRA
|
+$278K |
| 5 |
AngioDynamics
ANGO
|
+$277K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.42% |
| 2 | Healthcare | 13.76% |
| 3 | Financials | 12.63% |
| 4 | Consumer Discretionary | 11.69% |
| 5 | Technology | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
XWELL
XWEL
$8.53M
| $50K | 0.02% |
20
+3
| +18% | +$9.39K |
|
|
SMMF
1402
DELISTED
Summit Financial Group, Inc.
SMMF
| $50K | 0.02% |
1,823
-1,911
| -51% | -$44.8K |
|
|
DPLO
1403
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $50K | 0.02% |
3,967
+2,567
| +183% | +$47.8K |
|
1404
Airgain
AIRG
$67.7M
| $49K | 0.02% |
+3,400
| New | +$55.8K |
|
|
BPMC
1405
DELISTED
Blueprint Medicines
BPMC
| $49K | 0.02% |
1,748
-1,500
| -46% | -$45.2K |
|
1406
Boyd Gaming
BYD
$6.05B
| $49K | 0.02% |
2,421
-1,379
| -36% | -$26.5K |
|
1407
McDonald's
MCD
$193B
| $49K | 0.02% |
+400
| New | +$46.9K |
|
|
TTSH
1408
DELISTED
Tile Shop Holdings
TTSH
| $49K | 0.02% |
2,514
+653
| +35% | +$12.2K |
|
|
VRNT
1409
DELISTED
Verint Systems
VRNT
| $49K | 0.02% |
2,746
+196
| +8% | +$3.64K |
|
|
NBIS
1410
Nebius Group N.V.
NBIS
$69.3B
| $49K | 0.02% |
2,421
-2,979
| -55% | -$58.6K |
|
|
SYNC
1411
DELISTED
Synacor, Inc.
SYNC
| $49K | 0.02% |
+15,898
| New | +$47.2K |
|
|
NTRI
1412
DELISTED
NutriSystem, Inc.
NTRI
| $49K | 0.02% |
+1,400
| New | +$47.3K |
|
|
CASC
1413
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $49K | 0.02% |
11,284
+8,678
| +333% | +$56.1K |
|
1414
CorVel
CRVL
$3.25B
| $48K | 0.02% |
+3,948
| New | +$45.2K |
|
1415
Douglas Emmett
DEI
$1.99B
| $48K | 0.02% |
+1,300
| New | +$47K |
|
1416
FS KKR Capital
FSK
$3.49B
| $48K | 0.02% |
+1,162
| New | +$45.5K |
|
1417
Keysight
KEYS
$60.5B
| $48K | 0.02% |
1,300
+1,000
| +333% | +$34.5K |
|
1418
Primerica
PRI
$9.62B
| $48K | 0.02% |
700
-400
| -36% | -$25.4K |
|
1419
Stepan Co
SCL
$1.48B
| $48K | 0.02% |
587
+4
| +0.7% | +$309 |
|
|
OPB
1420
DELISTED
Opus Bank Common Stock
OPB
| $48K | 0.02% |
+1,595
| New | +$42.6K |
|
1421
Abeona Therapeutics
ABEO
$361M
| $47K | 0.02% |
391
+167
| +75% | +$26.1K |
|
1422
Amphastar Pharmaceuticals
AMPH
$858M
| $47K | 0.02% |
2,551
-3,140
| -55% | -$61.1K |
|
|
CMCM
1423
Cheetah Mobile
CMCM
$94.7M
| $47K | 0.02% |
+980
| New | +$52K |
|
1424
FS Bancorp
FSBW
$326M
| $47K | 0.02% |
+2,596
| New | +$41.7K |
|
1425
Lumentum
LITE
$78B
| $47K | 0.02% |
+1,207
| New | +$48K |
|
Similar funds
CRAM
ABFS
VHS
ACM
SIM
MC
TU
ASB
Acrospire Investment Management's Q4 2016 Portfolio in Review
As of Q4 2016, Acrospire Investment Management held 2,710 positions worth $243M, up 62% from $150M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.
Acrospire Investment Management deployed $78.7M of net new capital in Q4 2016, opening 740 new positions and adding to 896 existing holdings. Its largest new stake was Nomad Foods: 85,322 shares worth $817K.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ennis, an estimated $492K trimmed.
- Acrospire Investment Management's largest Q4 2016 buy was Nomad Foods: 85,322 shares worth $817K.
- Acrospire Investment Management added most to Nu Skin in Q4 2016, an estimated $560K increase.
- Acrospire Investment Management's biggest Q4 2016 reduction was Ennis, cutting an estimated $492K.
- Acrospire Investment Management fully exited HMS Holdings Corp. in Q4 2016, selling an estimated $279K.
- Acrospire Investment Management's ten largest holdings make up 2.7% of its $243M portfolio in Q4 2016.
- Acrospire Investment Management opened 740 new positions and closed 523 in Q4 2016.
- Acrospire Investment Management's portfolio value rose 62% quarter-over-quarter to $243M.
Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.